Results 21 to 30 of about 10,055 (118)

Measuring next of kin satisfaction with hospital cancer care: Using a mixed‐method approach as basis for improving quality and safety 衡量直系亲属对医院癌症护理的满意度:以混合法为基础提高质量和安全性

Journal of Advanced Nursing, Volume 76, Issue 5, Page 1232-1246, May 2020., 2020
Abstract Aim/s To explore next of kin satisfaction with cancer care, map next of kin suggestions for involvement and combine this information to create a basis for improving quality and safety in hospitals. Design Convergent parallel mixed‐methods design applying the 20‐item FAMCARE Scale survey instrument for quantitative measurement of satisfaction ...
Inger J. Bergerød, Ingvild Dalen, Geir S. Braut, Bjørnar Gilje, Siri Wiig   +4 more
wiley   +1 more source

Development of a Pt(II) compound based on indocyanine green@human serum albumin nanoparticles: integrating phototherapy, chemotherapy and immunotherapy to overcome tumor cisplatin resistance

Rare Metals, Volume 43, Issue 11, Page 6006-6022, November 2024.
Graphical abstract AbstractCisplatin resistance is the main cause for the failure of cancer therapy. To solve the problem, we proposed to develop a novel human serum albumin (HSA) nanoplatform to integrate chemotherapy, photothermal therapy (PTT) and immunotherapy.
Xue‐Yu Man, Ze‐Wen Sun, Shan‐He Li, Gang Xu, Wen‐Juan Li, Zhen‐Lei Zhang, Hong Liang, Feng Yang   +7 more
wiley   +1 more source

Abstracts

, 2022
Cancer Science, Volume 113, Issue S1, Page 1-1874, February 2022.
wiley   +1 more source

Inequalities in public funding: Are hospital‐based dental services funding models in Australia logical?

World Medical &Health Policy, Volume 16, Issue 2, Page 198-207, June 2024.
Abstract The availability of hospital‐based dental services across Australia varies with a number of hospitals disestablishing dental departments due to rising costs. However, the perceived costs are difficult to quantify as funding models used to capture activity are not uniform across health facilities.
Pritam Daniel Sundaresan, Estie Kruger, John Mc Geachie, Marc Tennant   +3 more
wiley   +1 more source

Abstracts of the 79th Annual Meeting of the Japanese Cancer Association; 2020 Oct 1‐3; Hiroshima, Japan as Cancer Science, Supplement 1, Vol 112 (2021)

, 2021
Cancer Science, Volume 112, Issue S1, Page 1-1072, February 2021.
wiley   +1 more source

Clinical Benefit of Sorafenib Combined with Paclitaxel and Carboplatin to a Patient with Metastatic Chemotherapy‐Refractory Testicular Tumors

The Oncologist, Volume 24, Issue 12, Page e1437-e1442, December 2019., 2019
Abstract Testicular cancer is one of the few tumor types that have not yet benefited from targeted therapy. Still no new active agents for treating this cancer have been identified over the past 15 years. Once patients are refractory to cisplatin‐based chemotherapy, they will be expected to die from testicular cancer.
Bijun Lian, Wenhui Zhang, Tiegong Wang, Qingsong Yang, Zepeng Jia, Huan Chen, Lei Wang, Jing Xu, Wei Wang, Kai Cao, Xu Gao, Yinghao Sun, Chengwei Shao, Zhiyong Liu, Jing Li   +14 more
wiley   +1 more source

Abstracts

Cancer Science, Volume 116, Issue S1, Page 1-1975, January 2025.
wiley   +2 more sources

癌基因C-myc在大肠癌中的表达及临床意义的研究

Zhongguo shiyan zhenduanxue, 2004
目的探讨癌基因Cmyc在大肠癌中的表达及临床意义。方法用免疫组织化学方法检测18例大肠癌组织及10例正常结肠粘膜组织中癌基因Cmyc的表达情况,并分析其与相关临床病理因素的关系。结果癌基因Cmyc蛋白表达阳性率在大肠癌组显著高于正常大肠粘膜组织。结论癌基因Cmyc蛋白在大肠癌组织中高度表达,但表达程度与癌症病理分级不相关。
姜涛, 田晓丰, 张广, 任辉, 张信   +4 more
doaj  

p16和bcl-2基因蛋白在大肠癌的表达及临床意义

Zhongguo shiyan zhenduanxue, 2006
目的探讨p16b、cl-2基因在大肠癌发生、发展中的作用以及临床中的意义。方法运用免疫组化技术检测大肠癌及腺瘤中p16、bcl-2基因蛋白的表达。结果p16基因蛋白阳性表达率在大肠癌及腺瘤中分别为35.90%、77.27%（P0.05）。p16与bcl-2基因蛋白表达在大肠癌中有相关关系,并与肿瘤分化程度、浆膜侵润、淋巴结转移有明显相关性,与年龄、性别、Dukes分期无相关性。结论p16基因的失活与bcl-2基因的过表达在大肠癌的发生、发展中起重要作用;大肠腺瘤是一种重要的癌前病变 ...
李潮, 李静, 李舒
doaj  

NGS法检测197例非小细胞肺癌突变基因特征分析

Zhongguo shiyan zhenduanxue, 2022
肺癌是全球癌症致死的首位原因,占癌症致死总数的18%[1]。非小细胞肺癌(NSCLC)是最常见的肺癌组织类型,我国NSCLC患者基因变异谱不同于西方人群,高达60%的肺腺癌患者具有已知的致癌基因突变[2]。近年,多项研究[3-5]采用二代测序方法针对晚期NSCLC进行多基因检测。通过对全景基因突变的了解,能够更好的指导临床治疗,以临床实验为主体的突变分布数据可以一定程度上反映NSCLC的驱动基因分布,特别是少见及罕见基因分布的了解,有助于进一步指导临床治疗 ...
doaj